secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sana Biotechnology, Inc. (SANA)
CIK:        0001770121
Form:       8-K
Filed at:   2026-05-15T20:06:25+00:00
Accession:  0001193125-26-226674
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Sana Biotechnology sells 21.6M shares for $69M in at-the-market offering
------------------------------------------------------------------------

- Sold 21,607,878 shares for net proceeds of approx. $69.0 million on May 15, 2026.
- Equity sale conducted under amended and restated sales agreement with TD Securities as agent.
- Offering utilized existing at-the-market facility; no new registration statement filed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1770121/000119312526226674/0001193125-26-226674-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1770121/000119312526226674/d135844d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-226674

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer